具有治疗潜力的耐药黑色素瘤的获得脆弱性
Liqin Wang1, Rodrigo Leite de Oliveira1, Sanne Huijberts2
1Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
抗药性黑色素瘤对活性氧物种 (ROS) 产生脆弱性. 沃里诺斯塔特的治疗选择性地向这些耐药细胞,为BRAF+MEK抑制剂耐药黑色素瘤提供了新的治疗策略.
科学领域:
- 癌症学
- 分子生物学
- 癌症治疗方法
背景情况:
- 突变的黑色素瘤往往会对BRAF和MEK激酶抑制剂产生耐药性.
- 这种耐药性经常与基激活蛋白激酶 (MAPK) 途径的重新激活有关.
研究的目的:
- 确定MAPK抑制剂耐药黑色素瘤的新疗法.
- 调查耐药黑色素瘤细胞中获得的脆弱性.
主要方法:
- 在抗性黑色素瘤细胞中评估反应性氧物种 (ROS) 水平.
- 使用基因组脱乙酶抑制剂沃里诺斯塔特向SLC7A11表达.
- 在老鼠模型和晚期黑色素瘤临床研究中评估瘤回归.
主要成果:
- 黑色素瘤对BRAF+MEK抑制剂的耐药性与ROS水平的增加相关.
- 沃里诺斯塔特治疗降低了SLC7A11,导致抗性细胞中致命的ROS积累.
- 在临床前和临床环境中观察到抗药性黑色素瘤细胞的选择性亡和显著的瘤回归.
结论:
- 针对BRAF+MEK抑制剂耐药性黑色素瘤的治疗方法是有前途的.
- 沃里诺斯塔特证明了选择性瘤细胞剥离,为这种新疗法提供了临床概念证明.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
相关概念视频
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
